TrialThe Journal of dermatology2026

Exploratory MRI and Clinical Marker Analysis of Pustulotic Arthro-Osteitis Disease Activity From a Phase 3 Brodalumab Trial.

Taiki Nozaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.